Locations:
February 7, 2025/Innovations

Cleveland Clinic Innovations 2024 Year in Review: Transforming Healthcare's Future

Cleveland Clinic Innovations (CCI) demonstrated exceptional performance in 2024, securing 144 patents, generating $27 million in licensing revenue, and investing $29 million in companies. The organization's achievements spanned technology development, international expansion, and capital raises, solidifying its position as a transformative force in healthcare innovation.

A Cleveland Clinic researcher looking through a microscope.

Cleveland Clinic Innovations (CCI) marked a transformative year in 2024, achieving significant milestones in healthcare innovation and commercialization. Key achievements included securing 144 issued patents, generating $27 million in licensing revenue through more than 50 new deals, and investing $29 million in companies. The organization's portfolio expanded with five new companies, while two existing portfolio companies successfully exited. Additionally, CCI’s portfolio companies raised an impressive $149 million in capital funding rounds during the year.

CCI's technology portfolio remained diverse, with medical devices comprising 50% of active technologies, followed by digital health and healthcare delivery solutions (27%), and therapeutics and diagnostics (23%). The organization maintained over 1,300 active technologies in development.

Internal to Cleveland Clinic, CCI reported 263 new Invention Disclosure Forms (IDFs) submitted, marking a 25% increase in submissions from 2023, a testament to the strength of CCI’s Engagement team and their ability to work with caregivers to identify and submit their ideas to help solve the most pressing unmet needs in healthcare.

The year also saw significant international expansion, with Cleveland Clinic London fully joining the Innovations ecosystem. Notable initiatives included an AI Roundtable in London and the establishment of a Global Venture Philanthropy Fund to accelerate commercialization of medical technologies.

These achievements in 2024 earned Cleveland Clinic recognition from both Fierce Healthcare and Fortune, with the latter ranking Cleveland Clinic among its Top 200 Companies for innovation commitment.

Under the leadership of Geoff Vince, PhD, Chief, Cleveland Clinic Innovations, the team continues to strengthen its position as a leading force in transforming healthcare through innovation and technological advancement.

Read Cleveland Clinic Innovations’ full 2024 year in review.

Subscribe to Cleveland Clinic Innovations' Newsletter

Follow Cleveland Clinic Innovations on LinkedIn

Latest from the Newsroom

Photo of scale wit a tape measure.

Cleveland Clinic Study Identifies Best Treatment Strategies for Weight Loss After Stopping GLP-1 Drugs

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

VeloSano riders

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years